Physician profile
Fredrick Odongo
NPI 1104582006
$39,095.24
in general payments reported to CMS, 2019-2025
8 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $240 · 2023: $184 · 2024: $510 · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $6,188 · Travel and Lodging: $3,468 · Food and Beverage: $1,896 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,192.00 |
| Consulting Fee | $6,187.50 |
| Travel and Lodging | $3,468.31 |
| Food and Beverage | $1,896.37 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $38,187.80 | 2022-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $330.11 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $272.27 | 2024-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $120.78 | 2022 | |
| Alkermes, INC. | $86.50 | 2022 | |
| Acadia Pharmaceuticals INC | $55.31 | 2024-2025 | Nuplazid |
| Alpha Cognition USA, INC. | $25.70 | 2025 | Zunveyl |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredrick Odongo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.